Results 31 to 40 of about 28,392 (204)
Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
Frontiers in Pharmacology, 2019 Olanzapine, a second-generation antipsychotic medication, plays a critical role in current treatment of schizophrenia (SCZ). It has been observed that the olanzapine responses in schizophrenia treatment are different across individuals.
Wei Zhou +12 more
doaj +1 more source
Bilateral Basal Ganglion Hemorrhage after Severe Olanzapine Intoxication
Case Reports in Psychiatry, 2020 Olanzapine is a second-generation antipsychotic drug which is generally considered safe with well therapeutic antipsychotic effects. We describe a patient suffering from bilateral intracerebral hemorrhage after severe olanzapine intoxication without ...
Kerstin Schweyer +5 more
doaj +1 more source
Pharmacovigilance on olanzapine
Indian Journal of Pharmacology, 2010 Sir, Pharmacovigilance, the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems, is highly essential in India, where there is a lack of adequate efficacy and safety-related data, limited efforts made on adverse drug reaction (ADR) monitoring by the ...
Lingeswaran, Anand +4 more
openaire +3 more sources
Olanzapine-induced restless leg syndrome (Willis–Ekbom disease): A case report
SAGE Open Medical Case Reports, 2022 Restless leg syndrome, also known as Willis–Ekbom disease, is a neurological sensorimotor disorder accompanied by an irresistible urge to move the legs with a fluctuating course of symptoms.
Soumitra Das +5 more
doaj +1 more source
Effect of Olanzapine on Metabolic Syndrome- A One Year Follow-up Study [PDF]
Journal of Clinical and Diagnostic Research, 2020 Introduction: Patients with schizophrenia have increased risk of cardiovascular mortality and this is partly attributed to antipsychotics. Olanzapine, one of first line antipsychotic for the management of schizophrenia is associated with Metabolic ...
KJ Samyukta +2 more
doaj +1 more source
Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis
Therapeutic Advances in Psychopharmacology, 2022 Numerous case reports of acute pancreatitis (AP) induced by olanzapine have been published. Little is, however, known about the clinical features of olanzapine-induced AP.
Yang He +7 more
doaj +1 more source
Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management
Advanced Science, EarlyView.ABSTRACT Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders.
Suneesh Thilak +9 more
wiley +1 more source
Olanzapine Overdose in a Pin Point Pupil with Altered Sensorium [PDF]
Asia Pacific Journal of Medical Toxicology, 2017 Background:Olanzapine is a highly tolerable and easily affordable atypical antipsychotic drug which has been commonly prescribed in both inpatient and outpatient settings for several mental disorders.
Naresh Midha +3 more
doaj +1 more source
Pathology and Oncology Research, 2022 Introduction: Olanzapine (OLZ) is one of the second-generation antipsychotics drugs (APDs) used to treat several psychiatric illnesses. Olanzapine treatment is often associated with many metabolic side effects in a dose dependent manner such as obesity ...
Mohammad AlQudah +7 more
doaj +1 more source
Melatonin Levels in 89 Individuals With Smith Magenis Syndrome
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT In patients with Smith–Magenis syndrome (SMS), an inverted circadian rhythm of melatonin (MT) contributes to the sleep disturbance. Standard treatment of sleep disturbance with MT often leads to extremely high daytime MT levels, resulting in even more sleep disorders. We therefore retrospectively evaluated the MT data of 89 SMS patients.
Wiebe Braam, Ann C. M. Smith
wiley +1 more source